Swiss Re

Swiss Re helps insurers and direct clients to shoulder risks through re/insurance and other solutions. Risk is our raw material. What we create is opportunity.

[Swiss Re @SwissRe]

🩺 Better cancer survival is changing more than patient outcomes. As survivorship grows, so does the need for long-term monitoring and managing recurrence and any residual treatment effects.

Discover more in our latest report: https://t.co/pOGPaTXMcT

[Swiss Re @SwissRe]

🧬 The biggest advances in cancer treatment aren't just new therapies. They're smarter ways of choosing them. Discover how precision oncology is helping make cancer treatment more personalised: https://t.co/2wXNTznzGX

[Swiss Re @SwissRe]

A global capex super-cycle is underway. AI data centres and renewable energy could generate ~USD 200 bn in cumulative commercial P&C premiums between 2026–2030.
But larger, more interconnected assets also increase risk accumulation.
Explore sigma 3/2026:https://t.co/b9xCka4GEe

[Swiss Re @SwissRe]

Our ambition is to become a leading AI-powered re/insurer. Discover how we’re putting that ambition into practice: https://t.co/p66f558vWF

[Swiss Re @SwissRe]

🧬 No two cancers are exactly alike. Increasingly, their treatment isn't either.

Discover how precision oncology, such as targeted therapies and immunotherapies, is driving more personalised cancer care in our latest report: https://t.co/mrph6lHSnE

[Swiss Re @SwissRe]

🌡️ Europe now experiences 64% more hot days than in the 1950s.

Explore our latest first-half 2026 natural catastrophe loss estimates, covering wildfire risk, insured losses and the North Atlantic hurricane outlook:
https://t.co/q9MQO9a0aQ

[Swiss Re @SwissRe]

Three markets. Three perspectives.
Explore what's shaping insurance across China, Europe and Japan in our latest regional analyses.
Learn more: https://t.co/9NHEffgxse

[Swiss Re @SwissRe]

64% more hot days in Europe. First-half 2026 insured natural catastrophe losses stayed below trend. Explore our latest 1H26 nat cat loss estimates, covering wildfire risk in Europe, US severe convective storms and the Atlantic hurricane outlook.
🔗 https://t.co/gYBoinMU1a

[Swiss Re @SwissRe]

🔬 Global age-standardised cancer mortality fell by 24% between 1990 and 2023, even as more people were diagnosed with cancer. Discover how advances in diagnosis and treatment are improving outcomes in our latest report. https://t.co/8tAPdieTrq

[Swiss Re @SwissRe]

Swiss Re has reported a strong first half of 2026, with a Group net income of USD 2.8 billion and improved earnings across all three Business Units. Learn more about our first-half 2026 financial results: https://t.co/FHeHXd3bla

[Swiss Re @SwissRe]

🩺 More people are surviving cancer than ever before. As survivorship grows, so do the implications for Life & Health insurance. Discover what advances in cancer treatment could mean for insurers in our latest report: https://t.co/2wXNTznzGX

[Swiss Re @SwissRe]

🧬 Cancer treatment is becoming increasingly personalised. Discover how targeted therapies and immunotherapy are helping change how cancer is treated: https://t.co/37CUi5QFB6

[Swiss Re @SwissRe]

🧬 Cancer treatment is entering a new era. From surgery, radiotherapy and chemotherapy to precision oncology such as targeted therapies and immunotherapy, and progress driven by AI, our latest report explores the future of personalised cancer care. https://t.co/Arv0VW2VJk

[Swiss Re @SwissRe]

🚨 Risk REconsidered returns with a fresh look! 🎧 Discover why the 2011 Thai floods still matter: watch now! #RiskREconsidered #podcast

[Swiss Re @SwissRe]

Recovery is only part of the resilience story. Measures that reduce risk before disaster strikes can help lower losses, support insurability and strengthen resilience over time. Read the latest sigma insights 👉 https://t.co/KYCmhlrtql

[Swiss Re @SwissRe]

🔬 Screening improves cancer outcomes, but uptake varies widely. Cervical screening ranges from 70–80% in some countries to below 50% in others. Access alone is not enough. Awareness and participation are major bottlenecks. https://t.co/LolsILdrrC

[Swiss Re @SwissRe]

The natural catastrophe protection gap widened to an estimated USD 424bn in 2025.
Not because protection is shrinking. Because exposure is growing. Learn more ➡️ https://t.co/y9Aj81O3i0

[Swiss Re @SwissRe]

🔬 Gaps remain in cancer detection. About 70% of US cancer deaths are linked to cancers without screening. New approaches like MCED and AI aim to detect cancers earlier, before a patient is symptomatic. Learn more 👉 https://t.co/NN5y3Ilt9L

[Swiss Re @SwissRe]

⚡The electric vehicle story is no longer just about adoption. Beyond innovation, the future of mobility may depend on how vehicles are repaired and insured. Read more: https://t.co/5s37Ucx5ov

[Swiss Re @SwissRe]

🔬 Overdiagnosis highlights a potential downside of increasingly sensitive cancer detection. Around 76% of thyroid cancer cases globally are linked to overdiagnosis, underscoring the need to balance early detection with unnecessary intervention. https://t.co/lWAy1k5oS3